peptideNot an approved drug anywhere; sold, when available at all, as an unregulated research chemicalThe cited literature itself calls DSIP's identity and mechanism an unresolved question, not an established sleep therapeutic
Delta Sleep-Inducing PeptideBenefits, Dosage & Interactions
Also known as: DSIP
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Insufficient — No primary literature attached to this entry yet.
Evidence strengthInsufficient — nothing graded yet
PreclinicalStrong human evidence
No primary literature attached to this entry yet.
Plasma half-life
Reported as very short in early animal work, but exact values are inconsistent across studies per the 2006 review
Typical timing
bedtime
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The cited reviews describe small human and animal studies from the 1970s-1990s using intravenous DSIP; no consistent dose range is established across them[1][2][3]
- Route studied
- Intravenous infusion in the small human studies discussed; the 2006 review notes its physiological role and even its status as a discrete peptide remain unresolved[1][2][3]
Reported for Delta Sleep-Inducing Peptide in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Delta Sleep-Inducing Peptide entry is written from. Each number matches an inline marker above.
- [1]Delta-sleep-inducing peptide (DSIP): a reviewGraf MV, Kastin AJ · Neuroscience and Biobehavioral Reviews · 1984 · Peer-reviewed · PMID 6145137
- [2]Delta-sleep-inducing peptide (DSIP): an updateGraf MV, Kastin AJ · Peptides · 1986 · Peer-reviewed · PMID 3550726
- [3]Delta sleep-inducing peptide (DSIP): a still unresolved riddleKovalzon VM, Strekalova TV · Journal of Neurochemistry · 2006 · Peer-reviewed · PMID 16539679
How to track Delta Sleep-Inducing Peptide doses
Delta Sleep-Inducing Peptide is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Delta Sleep-Inducing Peptide is stored as a concentration rather than a guess. DoseRoutine converts that into mg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mg and the frequency (typical timing: bedtime). Cycled protocols get a start and end date so the history stays accurate when Delta Sleep-Inducing Peptide comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Delta Sleep-Inducing Peptide alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
References & Evidence
Sources on this page that document Delta Sleep-Inducing Peptide dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Delta Sleep-Inducing Peptide studied for?
What is Delta Sleep-Inducing Peptide?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep. Research suggests DSIP plays a role in sleep regulation, stress response, and various physiological processes. While present endogenously, synthetic forms of DSIP have been investigated for potential therapeutic applications, particularly in areas related to sleep disturbances and mood regulation. It is typically administered via injection in research settings, due to its peptide nature which would be degraded by oral digestion. (DrugBank)
What does the research say about Delta Sleep-Inducing Peptide?
Tap a section to expand.
The precise mechanism of action of Delta Sleep-Inducing Peptide (DSIP) is not fully understood, but current research suggests it interacts with several neurotransmitter systems and neuronal pathways involved in sleep and stress. DSIP is believed to influence the regulation of the sleep-wake cycle through its effects on the central nervous system. Studies indicate it may modulate the activity of serotonin and dopamine systems, which are key in sleep initiation and maintenance. It is also thought to interact with the opioid system, potentially contributing to its stress-reducing and analgesic properties. DSIP has been shown to cross the blood-brain barrier, allowing it to exert its effects directly on brain structures involved in sleep regulation. Additionally, DSIP may influence neuroendocrine functions, including the release of pituitary hormones, which can indirectly impact sleep and stress responses. (PubChem)
Source for this section: Sources for How does Delta Sleep-Inducing Peptide work?: Jumps to this entry in the sources and references list at the end of the page.
Delta Sleep-Inducing Peptide (DSIP) has been investigated for several potential benefits, primarily related to sleep and neurological function:
* **Sleep Regulation**: The most prominent potential benefit of DSIP is its role in sleep induction and regulation. Early research showed its ability to increase delta wave sleep, which is characteristic of deep, restorative sleep. It may help normalize sleep patterns in individuals experiencing sleep disturbances, although more human studies are needed to confirm these effects consistently. (DrugBank)
* **Stress Reduction**: Some studies suggest DSIP may have an adaptogenic effect, helping the body cope with stress. It has been observed to influence stress hormone levels and improve behavioral responses to stressful situations in animal models. This could potentially translate to benefits for individuals experiencing chronic stress or anxiety. (PubChem)
* **Pain Modulation**: There is some evidence that DSIP may possess analgesic properties and could modulate pain perception. This effect is thought to be partly mediated through its interaction with the opioid system. Further research is required to explore its potential in pain management. (DrugBank)
* **Cognitive Function**: By improving sleep quality and reducing stress, DSIP might indirectly support cognitive functions such as memory and concentration. Some animal studies have also explored its potential direct neuroprotective effects, but these findings are preliminary. (PubChem)
Research on Delta Sleep-Inducing Peptide (DSIP) dates back to its discovery in 1977. Early studies, primarily in animals, demonstrated its ability to induce delta wave sleep, which is indicative of deep sleep. A review published in 'Peptides' summarized various animal studies showing DSIP's sedative and sleep-promoting effects, as well as its influence on stress responses and pain. Human studies on DSIP are more limited but have explored its potential in treating insomnia and improving mood. For instance, some small clinical trials have investigated DSIP's use in patients with sleep disorders, showing promising results in normalizing sleep patterns, though larger, more rigorous studies are needed to establish efficacy and safety broadly. (Cochrane Library reviews on specific sleep disorders might mention DSIP in their scope, but a direct Cochrane review on DSIP itself is not readily available as a primary evidence source). Overall, the evidence for DSIP's therapeutic use is still considered largely experimental, with much of the supporting data derived from preclinical animal models. (DrugBank, PubChem)
Given its status as a research peptide, comprehensive human safety data for Delta Sleep-Inducing Peptide (DSIP) are limited. Based on preclinical and limited clinical observations, potential side effects might include:
* **Injection site reactions**: As an injectable compound, redness, swelling, or pain at the injection site is possible.
* **Drowsiness or altered sleep patterns**: While intended to induce sleep, individual responses can vary, and some might experience excessive drowsiness or paradoxical sleep disturbances.
* **Headache**
* **Nausea**
Long-term side effects and interactions with other medications have not been extensively studied in humans. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Due to insufficient human safety data, several warnings are pertinent regarding Delta Sleep-Inducing Peptide (DSIP):
* **Lack of Regulatory Approval**: DSIP is not approved by the FDA or similar regulatory bodies for any medical use. Its use is primarily experimental or in research settings. (FDA label for DSIP does not exist)
* **Pregnant and Breastfeeding Individuals**: There is no data on the safety of DSIP during pregnancy or lactation. Therefore, it should be avoided by pregnant or breastfeeding individuals.
* **Children**: Safety and efficacy in pediatric populations have not been established.
* **Underlying Medical Conditions**: Individuals with pre-existing medical conditions, particularly neurological or endocrine disorders, should exercise extreme caution and consult a healthcare professional before considering DSIP, as its effects on these systems are not fully understood. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Specific contraindications for Delta Sleep-Inducing Peptide (DSIP) are not well-defined due to the limited scope of human research. However, based on its proposed mechanisms and general pharmacological principles, it would likely be contraindicated in:
* **Individuals with known hypersensitivity or allergic reactions** to DSIP or any of its excipients.
* **Pregnant or breastfeeding individuals** due to lack of safety data.
* **Children**.
* **Severe liver or kidney impairment**, as the metabolism and excretion of peptides can be affected, though specific studies on DSIP in these populations are lacking.
* **Individuals with severe neurological or psychiatric disorders**, unless carefully evaluated and monitored by a specialist, given its impact on brain activity. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Due to the limited research on Delta Sleep-Inducing Peptide (DSIP) in humans, specific drug-drug interactions are not well-documented. However, caution should be exercised when combining DSIP with:
* **Sedatives or Hypnotics**: As DSIP is believed to induce sleep, combining it with other sedatives (e.g., benzodiazepines, z-drugs, alcohol) could lead to excessive sedation, respiratory depression, or other adverse effects. The combined effects could be additive or synergistic.
* **Antidepressants or Anxiolytics**: Given DSIP's potential influence on neurotransmitter systems (like serotonin and dopamine), combining it with medications affecting these systems could theoretically lead to unpredictable interactions, either enhancing or diminishing their effects, or causing new side effects.
* **Opioid Pain Relievers**: DSIP is thought to interact with the opioid system. Concurrent use with opioid analgesics could potentially alter their efficacy or increase side effects.
* **Compounds affecting endocrine function**: Due to DSIP's potential influence on pituitary hormones, it may interact with compounds that also affect hormonal balance.
Always consult with a qualified clinician before combining DSIP with any other medications or supplements. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
The typical timing for Delta Sleep-Inducing Peptide (DSIP) administration, when used in research settings for its sleep-inducing properties, is before bedtime. This timing aligns with its intended effect of promoting sleep. Since it is an injectable peptide, its half-life of 1 hour suggests frequent administration might be needed for sustained effects. However, specific dosing protocols are user-directed and must be set by a licensed clinician. It is generally understood that food intake does not significantly impact the efficacy or absorption of injectable peptides like DSIP, so it can be administered either with or without food. (DrugBank)
Source for this section: Sources for When should you take Delta Sleep-Inducing Peptide?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Delta Sleep-Inducing Peptide?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Delta Sleep-Inducing Peptide
Delta Sleep-Inducing Peptide is a research peptide. It is also known as DSIP. The references summarized come from NIH and PubMed records, FDA labeling where it exists, and Mayo Clinic patient material.
Delta Sleep-Inducing Peptide is commonly discussed in the context of supporting brain. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Delta Sleep-Inducing Peptide, it is typically administered by injection and it is typically taken in the evening. Always follow the specific dose your clinician or the product label prescribes.
Delta Sleep-Inducing Peptide carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
As a peptide, Delta Sleep-Inducing Peptide can overlap with other supplements, prescription medicines, hormones and peptides. Because Delta Sleep-Inducing Peptide is usually taken in the evening, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Delta Sleep-Inducing Peptide with no sign-up.
Whether Delta Sleep-Inducing Peptide fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Published frequency for Delta Sleep-Inducing Peptide varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the evening. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Delta Sleep-Inducing Peptide depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Delta Sleep-Inducing Peptide the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Delta Sleep-Inducing Peptide?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions(opens PubMed in a new tab)J Am Acad Orthop Surg Glob Res Rev · 2026 · PMID 41490200 · https://pubmed.ncbi.nlm.nih.gov/41490200/
- 2.Delta sleep-inducing peptide(opens PubMed in a new tab)Eur J Anaesthesiol · 2001 · PMID 11437870 · https://pubmed.ncbi.nlm.nih.gov/11437870/
- 3.Peptides and the blood-brain barrier(opens PubMed in a new tab)Peptides · 2015 · PMID 25805003 · https://pubmed.ncbi.nlm.nih.gov/25805003/
- 4.Neuropeptides and human sleep(opens PubMed in a new tab)Sleep · 1997 · PMID 9456470 · https://pubmed.ncbi.nlm.nih.gov/9456470/
- 5.Delta-sleep-inducing peptide (DSIP): a review(opens PubMed in a new tab)Neurosci Biobehav Rev · 1984 · PMID 6145137 · https://pubmed.ncbi.nlm.nih.gov/6145137/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 68816(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/68816
Verify at
Publisher search links for Delta Sleep-Inducing Peptide. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Delta Sleep-Inducing Peptide?
Plain-text summary, safe to quote verbatim:
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep.
Source: DoseRoutine — https://doseroutine.com/library/delta-sleep-inducing-peptide
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Delta Sleep-Inducing Peptide — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/delta-sleep-inducing-peptide
What compounds are similar to Delta Sleep-Inducing Peptide?
Others in the peptide category or studied for the same goals.
Which goals is Delta Sleep-Inducing Peptide used for?
Other compounds studied for the same benefits as Delta Sleep-Inducing Peptide.
Continue exploring
See every compound DoseRoutine catalogs for these goals.